Glutamate receptor ionotropic, NMDA 1 (GRIN1) glycine binding site (GluN1 glycine site)

The NMDA receptor GluN1 glycine modulatory site is a distinct binding domain located on the GluN1 subunit of the N-methyl-D-aspartate (NMDA) receptor complex (UniProt: P17342). It is functionally unique because the NMDA receptor requires the simultaneous binding of two different agonists for activation: glutamate at the GluN2 subunit and a co-agonist, such as glycine or D-serine, at this specific GluN1 site (PubMed: 27016017). Often termed the "strychnine-insensitive glycine site," it serves as a critical gatekeeper for the receptor's ion channel, which is permeable to sodium, potassium, and calcium ions (StatPearls: NMDA Receptor). This site is essential for mediating synaptic plasticity, including long-term potentiation (LTP), which underlies learning and memory processes (NIH: GRIN1). In clinical contexts, NMDA receptor hypofunction via this site is strongly associated with the pathophysiology of schizophrenia, particularly its cognitive and negative symptoms (PubMed: 16007538). Conversely, excessive activation of the receptor can lead to calcium-mediated excitotoxicity, contributing to neuronal death in stroke and neurodegenerative diseases like Alzheimer's (PubMed: 11918951). Pharmacological strategies targeting this site include full or partial agonists to enhance NMDA signaling in psychiatric disorders and antagonists to provide neuroprotection or alleviate chronic pain (PubChem: Glycine).

Other names

Glycine-B siteStrychnine-insensitive glycine binding siteNMDA receptor glycine modulatory siteGRIN1 glycine site

The GluN1 glycine site serves as an obligatory co-agonist binding domain; the binding of glycine or D-serine is required alongside glutamate binding at the GluN2 subunit to trigger the opening of the NMDA receptor's cation-conducting pore.